Cluster of Excellence Precision Medicine in Chronic Inflammation (PMI)

About the Cluster

More and more people in industrial nations are suffering from chronic inflammatory diseases such as Crohn’s disease, psoriasis, diabetes and rheumatism. In the Cluster of Excellence “Precision Medicine in Chronic Inflammation” (PMI), scientists from various medical disciplines and fundamental research are working together on an interdisciplinary basis to significantly improve the diagnosis, treatment and prevention of these diseases. Their vision is to achieve complete control over the diseases – at every stage and as early as possible.

More about the Cluster of Excellence Precision Medicine in Chromic Inflammation (PMI)

Why precision medicine?

Precision medicine and PMI

Please note: Once you watch the video, data will be transmitted to Youtube/Google. For more information, see Google Privacy.

Cluster news

Vaccination syringe

COVID-19: mRNA vaccination is safe and effective even with chronic inflammatory diseases

For the first time, members of the Cluster of Excellence "Precision Medicine in Chronic Inflammation" have been able to demonstrate a safe and efficient immune response to COVID-19 mRNA vaccines in patients undergoing immunosuppressive therapy.

 
grafical image of a network

Kiel researchers develop software that reconstructs the metabolism of bacteria

The gapseq software uses information about genetic material to create computer models of bacteria.

 
Scientific illustration

SymbNET: European cooperation in symbiosis research

900,000 Euros in EU funds for international consortium including Kiel University for research on host-microbe symbioses

 
Frau hält Hände über Bauch

Breakthrough in the development of new anti-inflammatory therapies

Members of the Cluster of Excellence "Precision Medicine in Chronic Inflammation" (PMI) have demonstrated for the first time that a novel approach to treatment also works in patients with inflammatory bowel diseases.